Inflammatory Signals Enhance Piezo2-Mediated Mechanosensitive Currents  by Dubin, Adrienne E. et al.
Cell Reports
ReportInflammatory Signals Enhance
Piezo2-Mediated Mechanosensitive Currents
Adrienne E. Dubin,1,* Manuela Schmidt,1,3 Jayanti Mathur,2 Matthew J. Petrus,2 Bailong Xiao,1 Bertrand Coste,1
and Ardem Patapoutian1,2,*
1Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA
2Genomic Institute of the Novartis Research Foundation, San Diego, CA 92121, USA
3Present address: Max Planck Institute of Experimental Medicine, Go¨ttingen 37075, Germany
*Correspondence: adubin@scripps.edu (A.E.D.), apatapoutian@gnf.org (A.P.)
http://dx.doi.org/10.1016/j.celrep.2012.07.014SUMMARY
Heightened nociceptor function caused by inflam-
matory mediators such as bradykinin (BK) contrib-
utes to increased pain sensitivity (hyperalgesia) to
noxious mechanical and thermal stimuli. Although it
is known that sensitization of the heat transducer
TRPV1 largely subserves thermal hyperalgesia, the
cellular mechanisms underlying mechanical hyperal-
gesia have been elusive. The role of the mechanically
activated (MA) channel piezo2 (known as FAM38B)
present in mammalian sensory neurons is unknown.
We test the hypothesis that piezo2 activity is
enhanced by BK, an algogenic peptide that induces
mechanical hyperalgesia within minutes. Piezo2
current amplitude is increased and inactivation is
slowed by bradykinin receptor beta 2 (BDKRB2) acti-
vation in heterologous expression systems. Protein
kinase A (PKA) and protein kinase C (PKC) agonists
enhance piezo2 activity. BDKRB2-mediated effects
are abolished by PKA and PKC inhibitors. Finally,
piezo2-dependent MA currents in a class of native
sensory neurons are enhanced 8-fold by BK via
PKA and PKC. Thus, piezo2 sensitization may
contribute to PKA- and PKC-mediated mechanical
hyperalgesia.
INTRODUCTION
There is accumulating evidence that enhanced pain sensitivity
to noxious mechanical stimuli at sites of inflammation (primary
hyperalgesia) is due to peripheral sensitization of mechano-
transduction in nociceptors (Hucho and Levine, 2007; Woolf
and Ma, 2007). The cellular mechanisms underlying thermal hy-
peralgesia involve sensitization of the heat transducer TRPV1
(Huang et al., 2006). Although a variety of signaling pathways
contribute to the development and maintenance of mechanical
hyperalgesia (Hucho and Levine, 2007; Woolf and Ma, 2007),
the molecular mechanisms that lead to peripheral sensitization
of nociceptors have remained elusive (Lewin and Moshourab,
2004; Tsunozaki and Bautista, 2009; Woolf and Ma, 2007). TheCelrecently discovered MA ion channels piezo1 (known as
FAM38A) and piezo2 (known as FAM38B) (Coste et al., 2010,
2012) are expressed in mammalian skin and sensory dorsal
root ganglia (DRGs) (Coste et al., 2010). Piezo2 is expressed in
both myelinated and unmyelinated DRG neurons, some of which
coexpress the nocisensor TRPV1 (Coste et al., 2010), and there-
fore could play a role in mechanotransduction of noxious stimuli.
Indeed, the piezo protein in Drosophila contributes to mechan-
ical nociception (Kim et al., 2012). If mammalian piezo2 also
plays a role in mechanical hyperalgesia during inflammation, its
mechanical responses could be enhanced in response to inflam-
matory signals. The potent algogenic peptide bradykinin (BK)
plays an important role in acute mechanical hyperalgesia
observed after inflammation, largely through its activation of
bradykinin receptor beta 2 (BDKRB2) G protein coupled recep-
tors and downstream signaling pathways, including protein
kinase A (PKA) and protein kinase C (PKC) (Burgess et al.,
2000; Leeb-Lundberg et al., 2005; Mizumura et al., 2009;
Steranka et al., 1988). We tested the hypothesis that BDKRB2
activation enhances piezo2 activity. We found that piezo2-
dependent currents are dramatically increased in amplitude
and inactivation is slowed by activation of BDKRB2 in both
heterologous expression systems and native sensory neurons
through a mechanism that involves PKA and PKC.
RESULTS AND DISCUSSION
We first tested whether recombinant piezo2 could be modulated
by intracellular signaling pathways mobilized by BDKRB2
activation. We elicited piezo2-mediated currents by poking tran-
siently transfected HEK293T cells with a blunt glass probe
(Coste et al., 2010; McCarter et al., 1999). We cotransfected
recombinant piezo2 and BDKRB2 together with GFP to identify
transfected cells (piezo2+BDKRB2-HEK). BDKRB2 activation
by 300 nM BK robustly increased the amplitude of piezo2-
mediated MA currents and slowed inactivation (t-inac) (Fig-
ure 1A, red traces). The area under the curve (AUC; see Experi-
mental Procedures) indicating the net ion flux during mechanical
stimulation was enhanced 6.5-fold by BK compared with
vehicle-treated cells (Figure 1B). The kinetics of MA currents in
naive piezo2+BDKRB2-HEK cells were similar to those express-
ing piezo2 alone (piezo2-HEK; 5.0 ± 0.2 ms [n = 133] and 4.7 ±
0.2 ms [n = 124], respectively), revealing little or no constitutivel Reports 2, 511–517, September 27, 2012 ª2012 The Authors 511
Figure 1. Piezo2-Induced MA Currents in
HEK293T Cells Are Enhanced by BDKRB2
and G Protein Activation
(A) MA currents recorded at 80 mV in transiently
transfected piezo2+BDKRB2-HEK cells as a
function of probe displacement intensity before
(black) and during (red) exposure to 300 nM BK.
Below: The ramp (1 mm/ms)-and-hold mechanical
stimulation protocol. Inset: stimulus-response
curves before (black) and during BK exposure
(red).
(B) AUC is 6-fold larger in piezo2+BDKRB2-HEK
cells challenged with BK (red bar) compared
with vehicle-treated cells (p < 0.0001). The fold
change was determined for individual cells as the
value in the presence of BK normalized to that
obtained prior to BK exposure. Data are presented
as box and whiskers plots in which the bottom
and top of the box are the 25th and 75th percen-
tiles (lower and upper quartiles, respectively),
the band near the middle of the box is the
median, and the ends of thewhiskers represent the
minimum and maximum of all the data. Initial
values used to calculate fold changes are shown in
Table S1.
(C) The increase in piezo2 current amplitude
and t-inac (tau) by BK (plotted as fold change)
is concentration dependent [EC50: 28 nM,
95% confidence interval (%CI) 6–140 nM; and
20 nM, %CI 4–100 nM, respectively].
(D) Fold changes are shown for piezo2-dependent
current amplitude (left) and t-inac (right) during
application of vehicle only (clear bars), BK (red
bars), BK together with H0E-140 after 5 min pre-
incubation in HOE-140 (red hatched bars), and BK
10 min after intracellular perfusion with 667 mM
GDPbS-3Li (red stippled bars). Similar changes in
response to BK were observed for BK in the
presence of the vehicles DMSO (%0.3%), internal
LiCl (2 mM), and ethanol (%0.1%) for 5–10 min and
values are combined (red bars). Application of BK
at 100, 300, and 1,000 nM produced similar results
and the data are combined. *p < 0.05; **p < 0.01;
***p < 0.001 compared with BK; one-way ANOVA
with Newman-Keuls multiple-comparison post
hoc test.
(E) Intracellular GTPgS increases piezo2 amplitude, t-inac, and AUC compared with vehicle (2 mM LiCl) in piezo2-HEK cells. *p < 0.05; **p < 0.01;
***p < 0.005 using Student’s t test. The number of individual cells tested is shown above each bar. See also Table S1.BDKRB2 activity. Piezo2 activity was not influenced by BK (1 mM)
in the absence of BDKRB2 expression (data not shown). Exoge-
nous BDKRB2 activation enhanced piezo2 currents in other
cell lines (e.g., F-11 cells; data not shown). To determine whether
BK could have long-lasting effects on piezo2 currents, we
recorded from piezo2+BDKRB2-HEK cells preexposed to BK
and compared their MA currents with those in control cells that
were never exposed to BK. MA currents from cells preexposed
to 0.3–1 mM BK revealed longer decay times (t-inac = 12.1 ±
1.6 ms, n = 9) compared with naive cells (5.4 ± 0.4 ms, n = 20;
p < 0.005), suggesting a long-lasting modulation in intact cells.
BK-induced increases in amplitude and t-inac were similarly
dependent on the BK concentration, with EC50 25 nM (Fig-
ure 1C), as expected for a requirement of BDKRB2 activation
(Leeb-Lundberg et al., 2005; Mizumura et al., 2009). Exposure512 Cell Reports 2, 511–517, September 27, 2012 ª2012 The Authorof piezo2+BDKRB2-HEK cells to BK produced a small inward
current (185 ± 35 pA at 80 mV; n = 25) with a latency of
34 ± 3 s (n = 25), but there was no correlation between MA Imax
and BK-induced holding current, which suggests that piezo2
was not directly activated by BDKRB2 activation (data not
shown). The estimated latency for the BK-induced enhancement
of piezo2 (determined during application of a constant stimulus,
at 25% of Imax, every 5 s) was 52 ± 5 s (n = 16). Exogenous
BDKRB2 was required for the enhancement of piezo2-mediated
MA currents because the specific BDKRB2 antagonist HOE-140
blocked the BK effect on piezo2 currents (Figure 1D; BK+HOE-
140). HOE-140 exposure had no effect on naive piezo2-
mediated currents in piezo2+BDKRB2-HEK cells (data not
shown), consistent with a lack of constitutive BDKRB2 activity.
Changes in both piezo2 current amplitude and t-inac requireds
Figure 2. PKA and PKC Enhance Piezo2-Dependent Currents
(A) Piezo2MAcurrent amplitude, time course of decay and AUC in Piezo2-HEK
cells are enhanced by 8-BrcAMP (100–300 mM; pink bars) and PMA (1 mM;
green bars), but not the inactive congener 4aPMA (1 mM; hatched bars). Effects
during application of both agonists together were not significantly different
from those observed with either agonist alone. *p < 0.05; **p < 0.01; ***p < 0.01
compared with vehicle; one-way ANOVA with Newman-Keuls multiple-
comparison post hoc test.
(B) Recordings showing modulation of piezo2-dependent currents by 8-
BrcAMP andPMA. Inset: Peak current-displacement curves for control (black),
presence of both agonists (red), and washout (open circles).
CelG protein activation because inclusion of GDPbS (667 mM) in
the pipette occluded both effects on amplitude and t-inac
(Figure 1D; BK+GDPbS). Furthermore, intracellular GTPgS
(500 mM) enhanced theMA amplitude, t-inac, and AUC of piezo2
over 3–25 min compared with vehicle controls (Figure 1E). After
30 min in G protein bg inhibitor gallein (30 mM), piezo2 currents
were still effectively increased by BK in the continued presence
of gallein, indicating a major role for G protein a subunits (ampli-
tude: 2.0 ± 0.2-fold, p < 0.05 compared with changes in the pres-
ence of vehicle; t-inac: 1.7 ± 0.1-fold, p < 0.05).
Because BDKRB2 can couple to Gas, Gaq, Gai, and Gao, we
pharmacologically assessed the role of intracellular signaling
pathways regulated by these G proteins. Given the known roles
of PKA and PKC in mechanical hyperalgesia (Bhave and Gereau,
2004; Hucho and Levine, 2007), we tested whether agonists of
these kinases could enhance recombinant piezo2 currents. We
assessed the potential role of the cAMP/PKA pathway using
the membrane-permeable analog of cAMP, 8-BrcAMP, to acti-
vate PKA directly. Exposure of cells to 100–300 mM 8-BrcAMP
increased amplitude, t-inac, and AUC (Figure 2A, rose bars).
The PKC activator PMA (1 mM) was similarly effective (Figure 2A,
green bars), whereas the inactive congener 4aPMA had no effect
(hatched bars). A combination of 8-BrcAMP and PMA had no
apparent additive effect (Figure 2A, brown stippled bars). An
example of MA currents reversibly modulated by both agonists
is shown in Figure 2B. The PKA inhibitor H-89 (10 mM) and
PKC inhibitor BIM I (1 mM) applied together effectively abrogated
the BK-induced changes in both parameters (Figure 2C, brown
bars), whereas antagonists applied alone were significantly
less effective, if at all (Figure 2C), suggesting that both PKA
and PKC pathways are capable of similarly modulating piezo2.
BK increases intracellular calcium largely through activation of
the Gaq pathway (Leeb-Lundberg et al., 2005; Mizumura et al.,
2009). We tested whether phospholipase C (PLC) and/or intra-
cellular calcium were required for BK modulation of piezo2. No
enhancement of piezo2-mediated currents was observed during
4–5 min exposure to the PLC activator m-3M3FBS (Bae et al.,
2003) (25 mM), suggesting that phosphatidylinositol (PI)-PLC
pathways do not increase piezo2 activity (Figure S1, hatched
bars). In the same heterologous system and under the same
recording conditions, m-3M3FBS enhanced TRPA1 channel
activity with a latency of 30–45 s (data not shown), consistent
with PLC-dependent activation of TRPA1 (Dai et al., 2007).
Consistent with the inability of the PI-PLC activator to modulate
piezo2, inhibition of PI-PLC isoforms byU73122 (Bleasdale et al.,
1990) or Et-18-OCH3 (edelfosine; Powis et al., 1992) for up to 3 hr
had no effect on BK-induced changes (Figure S1), although both
inhibitors blockedBK-induced uncoupling of clusteredHEK293T
cells more effectively compared with controls that included
inactive U73343 (Hofgaard et al., 2008; van Zeijl et al., 2007;
data not shown). Inhibition of store release by thapsigargin(C) Combined inhibition of PKA (H89, 10 mM) and PKC (BIM I, 1 mM; red
hatched bars), but not H89 (orange bars) or BIM I (green bars) alone, abrogated
BK effects on both MA amplitude (top) and t-inac (bottom) in piezo2+
BDKRB2-HEK cells. *p < 0.01; **p < 0.001 compared with BK; one-way
ANOVA with Newman-Keuls multiple-comparison post hoc test. See also
Table S1 and Figures S1 and S2.
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Figure 3. Piezo2-Dependent Currents in
a Class of DRG Neurons Are Enhanced by
Endogenous BDKRB2 Activation
(A) Inkblot neuron 1 day after plating in NT-4- and
NGF-containing media.
(B) siRNA pool against piezo2 reduces MA current
density in Inkblot neurons 3 days after nucleo-
fection (RNAi) compared with scrambled (Scr)
controls (gray bars), and has no significant effect
on MA current density of Rosette neurons (pink
bars). Four separate experiments.
(C) Families of whole-cell MA currents elicited by
increasing probe displacement before (black) and
with BK (1 mM) after 5 min of exposure (red); t-inac
values are shown. Inset: Peak current as a function
of displacement.
(D) BK increases amplitude and AUC, and
prolongs the decay time course (tau) through
activation of endogenous BDKRB2 (red bars)
compared with vehicle (clear bars). Cells pre-
treated with 1–2 mM HOE-140 for 5 min prior to BK
(100–300 nM) exposure in the continued presence
of HOE-140 significantly suppressed BK effects.
**p < 0.01; ***p < 0.001; one-way ANOVA with
Newman-Keuls multiple-comparison post hoc
test.
(E) PKA and PKC inhibition abolished BK effects on
Inkblot neurons. *p < 0.05; ***p < 0.001 compared
with BK using Student’s t test. See also Table S1.(TG; 1 mM) also had no effect on BK-induced changes in piezo2
currents (Figure S1), consistent with previous work on rapidly
adapting (RA) currents in DRG neurons (Rugiero et al., 2010;
A.E.D., unpublished data) that are largely mediated by piezo2
(Coste et al., 2010). Because BK is known to activate Gao (an
activator of PC-PLC; Kennedy et al., 1996), we investigated the
role of PC-PLC using the Gai/Gao inhibitor pertussis toxin (PTX;
100–200 ng/ml, 6–24 hr) and the PC-PLC inhibitor D609
(100 mM, R15 min). Neither agent reduced the BK-induced
enhancement, although PKA inhibitors were not included in
these studies (Figure S1 and data not shown). Long exposures
to PTX, U73122, edelfosine, TG, and D609 had no effect on initial
piezo2 amplitude or t-inac values (Table S1).514 Cell Reports 2, 511–517, September 27, 2012 ª2012 The AuthorsWe next sought to determine whether
piezo2 expressed in native sensory
neurons could be sensitized by BK. We
previously showed that 20% of cultured
adult DRG neurons express RA MA
currents, and this population is largely
reduced by piezo2 RNA interference
(RNAi) treatment (Coste et al., 2010).
However, since specific markers for this
population are unavailable, we tested
whether RA MA currents might be en-
riched in a morphologically distinct popu-
lation and whether these currents were
dependent on piezo2. Rosette neurons
have been reported to express RA MA
currents (Coste et al., 2007; Dubreuil
et al., 2004) and are identifiable after16 hr when cultured with the BDNF receptor agonist NT-4
(Lindsay, 1988) together with nerve growth factor (NGF).
Although some Rosette neurons displayed RAMA currents, their
t-inac ranged from 2 to 54 ms (t-inac = 15 ± 2 ms, n = 25). We
then screened neurons having distinctive morphologies (e.g.,
neurons with flattened processes or neurons with extremely
long, thin branching processes essentially lacking varicosities)
for a population expressing RA currents similar to those medi-
ated by heterologously expressed piezo2. Remarkably, >95%
of a population of small–medium neurons (soma diameter:
27 ± 1 mm, n = 73; Cm: 49 ± 2pF, n = 96) with flattened processes
(Figure 3A) and incidence similar to that of Rosettes (2%–5%
of cultured neurons; data not shown) displayed RA MA currents
(t-inac = 6.3 ± 0.4 ms; n = 95). We dubbed these neurons
‘‘Inkblots’’ (see criteria in Experimental Procedures). Although
medium-diameter RA MA fibers are generally considered non-
nociceptive, both C and Ad fibers with RA responses encoding
mechanical stimuli into the noxious range have been reported
(Andrew and Greenspan, 1999; Boada and Woodbury, 2007;
Potenzieri et al., 2008). Naive Inkblots revealed prolonged action
potential (AP) durations (3.1 ± 0.3 ms, n = 33) and sensitivity to
capsaicin (five of five Inkblots tested revealed an increase in
conductance to 1 mM capsaicin (45 ± 25 nS, range 3–113 nS;
Cm: 60 ± 15 pF), consistent with their being nociceptors (Djouhri
et al., 1998). Nucleofection of neuronal cultures with siRNA
directed to piezo2 (Coste et al., 2010) selectively decreased
the MA current density in these neurons compared with scram-
bled siRNA controls (Figure 3B, gray bars), and had no significant
effect onMA currents elicited in Rosette neurons (Figure 3B, rose
bars), providing strong evidence that MA currents in Inkblot
neurons are largely if not wholly dependent on piezo2. We do
not currently know whether Inkblots define a relevant population
in vivo, but this is not important for our purpose. The identifica-
tion of a morphologically distinct population that displays rapid
RA currents that depend on piezo2 expression enabled us to
address the regulation of endogenous piezo2, which would
have been much more difficult using a blind approach. Indeed,
although Inkblots represent only a subpopulation of small–
medium neurons expressing piezo2 (Coste et al., 2010), our
ability to identify a native cell population expressing piezo2
enabled us to test whether BK modulated RA MA currents. In
all 18 neurons tested, BK (100–1000 nM) robustly increased
current amplitude (3.6-fold) and t-inac (1.9-fold; Figure 3C)
compared with vehicle controls, which showed a slight rundown
and acceleration of t-inac over 25 min (Figures 3C and 3D, clear
versus solid red boxes). The AUC revealed a dramatic 7.7-fold
increase in the presence of BK (Figure 3D, right panel) and partial
reversibility during washout under these recording conditions
(data not shown). The latency for the BK effect on MA currents
was 55 ± 8 s (n = 6). These effects are remarkably similar to
modulation of recombinant piezo2 in HEK293T cells. Also similar
to the case with piezo2+BDKRB2-HEK cells was the lack of
correlation between the magnitude of the RA currents and the
change in holding current at 80 mV during the BK-induced
effect on Inkblots (data not shown). HOE-140 blocked the BK-
induced modulation, indicating that endogenous BDKRB2 was
responsible for the observed effects (Figure 3D, red hatched).
We reasoned that if themechanisms underlying piezo2 regula-
tion in Inkblots were similar to those in piezo2+BDKRB2-HEK
cells, then PKA and PKC inhibitors should reduce BK effects
on native MA currents. Indeed, the combination of antagonists
abrogated the BK-induced facilitation (Figure 3E), suggesting
that the heterologous system could recapitulate native neuronal
mechanisms. The molecular identity of the downstream target(s)
that lead to augmented piezo2 activity is unknown, but they may
include piezo2 (Coste et al., 2012), piezo2-associated proteins,
or other signaling components. Piezo2 is encoded by >2,500
amino acids and contains putative consensus PKA and PKC
phosphorylation sites. Of these 39 sites, four putative PKC
sites are likely to be in transmembrane domains according to
the Kyte-Doolittle hydrophobicity prediction (Figure S2). Site-Celdirected mutagenesis of these sites and/or the acquisition of
an efficient antibody will enable investigators to test the hypo-
thesis that piezo2 is directly phosphorylated by BDKRB2
activation.
These data indicate that piezo2-dependent RA channel
activity is enhanced by a potent inflammatory algogen through
activation of PKA and PKC in both heterologous expression
systems and native sensory cells. We suggest that upmodulation
of piezo2 activity contributes, at least in part, to inflammatory
mechanical hyperalgesia. Because piezo2 constitutive knockout
mice died at birth (data not shown) and attempts to knock
down RNAi by intrathecal injection of piezo2 siRNA had no
effect on transcript levels in the lumbar DRG, a definitive in vivo
demonstration of a role for piezo2 in BK-induced mechanical
hyperalgesia will have to await the development of conditional
knockout mice. PKA and certain PKC isoforms play important
roles in mechanical hyperalgesia (Hucho and Levine, 2007;
Khasar et al., 1999a, 1999b; Koda and Mizumura, 2002). The
mechanism described here differs from another model of
mechanical hyperalgesia (epinephrine-induced PKCε-mediated)
in which the downstream effector of cAMP is EPAC rather than
PKA, since the BK effects observed here require PKA activity,
and neither PI-PLC (Hucho et al., 2005) nor phospholipase D
(Lo´pez De Jesu´s et al., 2006) appears to be involved.
Inhibition of both kinases is required to block the effects of
BK, suggesting the involvement of parallel PKA and PKC
pathways. BK-induced mechanical activity in sensory neurons
was observed in a number of studies that also implicated
cAMP (through an unknown effector) and PKC activation as an
underlying mechanism (Dray et al., 1992; Koda and Mizumura,
2002). Although five PKC isoforms in DRG neurons have been
reported, BK has been shown to sensitize DRG neurons by
translocating PKCε to the membrane (Cesare et al., 1999). In
our heterologous system, we found that activation of PKA and
PKC by coapplication of 8-BrcAMP and PMA to piezo2-HEK
cells was less effective at modulating piezo2 than BDKRB2
activation in piezo2+BDKRB2-HEK cells (compare Figure 2A
and Figures 1B and 1D). However, the BK response was nearly
completely blocked by the combination of PKA and PKC inhibi-
tors. There are several possible explanations for this, including
the higher efficiency of local changes in signaling during BK
exposure compared with global increases in PKA and PKC
agonists, and the involvement of other downstream signaling
pathways.
Here we establish the framework for a signal transduction
pathway that is initiated by an inflammatory mediator and culmi-
nates in the hyperactivity of a mechanotransduction channel in
mammalian somatosensory neurons. Future work will determine
the role of piezo2 in the mechanosensitivity of sensory neurons
that innervate different targets (e.g., cutaneous, deep-tissue,
and/or visceral targets) and the underlying molecular mecha-
nisms by which piezo2 MA activity is modulated by intracellular
signaling.EXPERIMENTAL PROCEDURES
All animal protocols were approved by The Scripps Research Institute
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guidelines and public law, and all experiments conformed to the relevant
regulatory standards. The methods used are essentially as described in Coste
et al. (2010) with certain exceptions as described below.
DRG Cell Culture and Selection
DRG neurons from all spinal levels were cultured in NT-4 (50 ng/ml) and NGF
(100 ng/ml) at low density and tested 16–72 hr after plating. Medium-sized
neurons with very flattened growth cones were first described in low-density
cultures exposed to BDNF (see Figure 2D in Lindsay, 1988), and we dub
them Inkblots. The following six criteria were used to identify an Inkblot neuron:
small–medium diameter (10–37 mm; criterion 1) with one to five dark phase,
flattened primary extensions (criterion 2) that do not extend beyond six
soma diameters (criterion 3), at least one of which partially wraps around the
soma (criterion 4). The processes harbor short, flattened secondary processes
(criterion 5) with a few large varicosities, particularly at branch points (criterion
6). For typical Inkblots that were well separated from nearby cells, the apparent
number of primary processes was 3 ± 1, the number of branch points was
45 ± 6, and the arbor size (at 16–24 hr) per soma diameter was 4.5 ± 0.4
(n = 6). RA MA characteristics and fold changes induced by BK were similar
in 1-day-old and older cultures, and a trend toward smaller MA current ampli-
tude at 2–3 days was not significant.
HEK293T Cell Culture
HEK cells were transiently transfected with 0.6 mg piezo2-pSPORT6 cDNA/ml
and 0.3 mg pHAGE CMG ZsGreen cDNA with or without 1 mg/ml human
Bdkrb2-pcDNA3.1+ cDNA. Selected cells appeared well attached as single
cells or in pairs, or in small clusters of up to five cells, with one to two GFP+
cells per cluster. Cells were maintained at moderate confluence through 14
passages or until their responsiveness to BK was poor when transfected
with piezo2 and Bdkrb2 constructs.
Electrophysiology
The DRG intracellular solution consisted of (in mM) 125 K-gluconate, 7 KCl,
1 CaCl2, 1 MgCl2, 10 HEPES, 1 tetraK-BAPTA, 4 Mg-ATP, 0.5 Na-GTP
(pH 7.3 with KOH). To improve retention of intracellular constituents, we
achieved a resistive whole-cell configuration using the zap function on the
amplifier (Multiclamp700A; Dubin and Dionne, 1993) for access resistances
(Ra) 12–30 MU (DRG: 21.9 ± 1.1 MU [n = 42]; HEK: 18.1 ± 0.3 MU [n = 371])
that were monitored throughout the experiment. Data were accepted only if
Ra was stable. The capacitance was continuously or frequently monitored to
identify electrical uncoupling in the presence of BK. To avoid tachyphylaxis
to BK and preexposure to other pharmacological tools, only a single cell per
coverslip was tested.
Mechanical Stimulation
We took an approach that enabled comparisons of piezo2-dependent currents
over a 20 min period after they stabilized (which occurred 5–7 min after initi-
ating recordings). Cells were usually challenged with increasing probe
displacements in increments of 0.5 or 0.7 mm from just below threshold to
well above half-maximal response to acquire sigmoidal stimulation-response
curves (Figure 1A, inset) to enable the calculation of Imax for each cell before,
during, and after exposure to modulators. Thus, families of currents elicited
by increasing stimulus intensity (Figure 1A) were acquired every 1–1.5 min to
monitor Imax and holding current. Control experiments to address tachyphy-
laxis to mechanical stimuli revealed that responses near Imax were similar for
single largemagnitude displacements and the same displacement after under-
going stimulus-response protocols in 0.7 mm increments. Piezo2-dependent
currents were stable with interstimulus intervals of 5 or 10 s. Modulators
were bath applied only after consistent baseline responses to increasing
displacements to >50% Imax were observed (7 min for HEK and 5 min for
DRG; sampling interval: 50 ms; filter: 10 KHz).
Statistical Analysis
Statistical significance between groupswas evaluated using Student’s t test or
one-way ANOVA with Newman-Keuls multiple-comparison post hoc test. Imax
was determined by fitting peak current versus probe displacement with
a sigmoidal dose response with variable slope (GraphPad Prizm 4 (v4.03))516 Cell Reports 2, 511–517, September 27, 2012 ª2012 The Authorfor control (Imax(control)) and modulator-stimulated currents (Imax(mod)), and the
fold change was calculated as Imax(mod)/Imax(control). t-Inac was determined
by fitting the decay phase of currents 20%–50% of Imax with a single expo-
nential, and fold change was calculated as t(mod)/t(control). Currents in the range
of 20%–50% Imax were averaged over 150 ms and the AUC was determined
using Clampfit and IGOR Pro 5.04B (V_sum in Wave stats). Pharmacological
tools are listed in the Extended Experimental Procedures.
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